Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: A meta‐analysis
Authors:
- 15 April 2008
- journal article
- research article
- Published by Wiley in Respirology
- Vol. 13 (4) , 518-527
Abstract
Background and objective: Conventional tests are not always helpful in making a diagnosis of malignant pleural effusion (MPE). Many studies have investigated the utility of pleural carcinoembryonic antigen (CEA) in the early diagnosis of MPE. The present meta‐analysis determined the accuracy of CEA measurement in the diagnosis of MPE.Methods: A systematic review of English language studies was conducted and data on the accuracy of pleural CEA concentrations in the diagnosis of MPE were pooled using random effects models. Receiver operating characteristic curves were used to summarize the overall test performance.Results: Forty‐five studies met the inclusion criteria for the meta‐analysis. The summary estimates for CEA in the diagnosis of MPE were: sensitivity 0.54 (95% CI: 0.52–0.55), specificity 0.94 (95% CI: 0.93–0.95), positive likelihood ratio 9.52 (95% CI: 6.97–13.01), negative likelihood ratio 0.49 (95% CI: 0.44–0.54) and diagnostic odds ratio 22.5 (95% CI: 15.6–32.5). Analysis of a subset of 11 studies which examined the value of pleural CEA in ruling out a diagnosis of malignant mesothelioma found that the sensitivity and specificity of a CEA level exceeding cut‐off values were 0.97 (95% CI: 0.93–0.99) and 0.60 (95% CI: 0.55–0.65), respectively.Conclusions: Measurement of pleural CEA is likely to be a useful diagnostic tool for confirming MPE, and is also helpful in the differential diagnosis between malignant pleural mesothelioma and metastatic lung cancer. The results of CEA assays should be interpreted in parallel with clinical findings and the results of conventional tests.Keywords
This publication has 83 references indexed in Scilit:
- Significance of tumor markers in lung cancerIndian Journal of Clinical Biochemistry, 2006
- Diagnostic Value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 Assays in Pleural Effusions: Analysis of 116 Cases and Review of the LiteratureThe Oncologist, 2005
- Advances in the diagnosis, evaluation, and management of malignant pleural mesotheliomaRespirology, 2005
- Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levelsEuropean Journal of Cancer, 1993
- New strategies are needed in diffuse malignant mesotheliomaCancer, 1992
- Tumour associated antigens in diagnosis of serous effusions.Journal of Clinical Pathology, 1988
- Detection of malignant pleural effusions by tumor marker evaluationEuropean Journal of Cancer and Clinical Oncology, 1988
- The role of concurrent determinations of pleural fluid and tissue carcinoembryonic antigen in the distinction of malignant mesothelioma from metastatic pleural malignanciesEuropean Journal of Cancer and Clinical Oncology, 1985
- Carcinoembryonic antigen in pleural effusions. Diagnostic value in malignant mesotheliomaCancer, 1984
- Carcinoembryonic antigen in pleural effusions: A diagnostic and prognostic indicator1980